Can Capsule Endoscopy Be Retained in the Colon?
Yes, capsule endoscopy can be retained in the colon, though this is uncommon—the capsule can become trapped at stricturing disease sites anywhere in the gastrointestinal tract including the colon, particularly in patients with Crohn's disease, prior abdominal surgery, or intestinal obstruction. 1, 2
Understanding Capsule Retention Sites
While the small bowel is the most common site of capsule retention (occurring in approximately 68% of retention cases), the colon accounts for approximately 8% of retention events. 3 The capsule can become lodged at any strictured segment of the gastrointestinal tract, including:
- Small bowel (most common site—17 of 25 retention cases in one large series) 3
- Colon (documented in multiple case reports and series) 4, 3
- Esophagus and stomach (less common) 3
A particularly instructive case involved a patient with known Crohn's disease who had colonic involvement—the capsule became trapped in a metal stent placed in the sigmoid colon, causing bowel obstruction requiring emergency surgery. 4 This demonstrates that colonic retention is not merely theoretical but a documented clinical reality.
Risk Factors for Capsule Retention (Including Colonic)
The overall risk of capsule retention varies dramatically based on patient population:
- Suspected Crohn's disease without obstructive symptoms: 3.6% retention risk 5, 1, 2
- Established/known Crohn's disease: 8.2% retention risk 1, 2
- Obscure GI bleeding: 1.3% retention risk 3
High-Risk Patient Characteristics
Patients at elevated risk for retention (at any site including colon) include those with: 1, 2
- History of obstructive symptoms (abdominal pain, distension, nausea, vomiting)
- Known stricturing Crohn's disease
- Previous small bowel resection or intestinal anastomosis
- History of abdominal or pelvic radiation exposure
- Chronic NSAID use
- Presence of gastrointestinal stents 4
Risk Mitigation Strategy Before Capsule Endoscopy
When obstructive symptoms are present or in known stricturing Crohn's disease, a patency capsule should precede capsule endoscopy. 5, 1
Pre-Procedure Assessment Algorithm
Screen for obstructive symptoms (pain, distension, nausea, vomiting) 2
In established Crohn's disease: Perform cross-sectional imaging (MRI or CT enterography) or patency capsule before capsule endoscopy to identify stenosis 5, 1
In suspected Crohn's disease with high clinical suspicion:
Critical Caveat About Patency Capsules
Even patency capsules can cause symptomatic retention and severe complications including perforation with peritonitis. 2, 6 One case series documented two patients with suspected Crohn's disease who experienced significant symptoms from retained patency capsules—one developed small bowel perforation requiring aggressive intervention. 6 Additionally, capsule retention can still occur in 2.7% of patients even after successful patency capsule passage. 2
Management When Retention Occurs
Most capsule retention cases can be managed conservatively with favorable clinical outcomes, and only a minority require emergency intervention. 5, 3
Management Options (in order of invasiveness):
Conservative/medical management: Steroid treatment in Crohn's disease patients (3 cases resolved in one series) 3
Spontaneous passage: Some capsules dislodge without intervention (3 cases in one series) 3
Device-assisted enteroscopy: Endoscopic retrieval when conservative measures fail 5, 3
Elective surgery: Required in approximately 24% of retention cases (6 of 25 cases) 3
Emergency intervention: Needed in only 20% of retention cases (5 of 25 cases required emergency endoscopy or surgery) 3
Important Clinical Perspective
Capsule retention may actually indicate the presence of a clinically significant lesion requiring surgical intervention, making retention a diagnostic finding rather than purely a complication. 7 In one series of 19 patients with suspected small bowel obstruction who underwent capsule endoscopy, the capsule was retained in 4 cases—all 4 had obstructing lesions that were electively resected without complications, and no case resulted in acute bowel obstruction from capsule administration. 7
The retained capsule essentially "marks" the site of pathology requiring intervention, which can be viewed as clinically useful information rather than an adverse event in selected cases. 7